Cellebrite DI Ltd. (CLBT) Stock Analysis and Metrics

Cellebrite DI

NASDAQ: CLBT

$16.47 ▼ -0.10 (-0.63%)

At close: Jul 8, 2026 · 2:52 PM UTC

Financial Ratios

Market Cap3.73 Bn

P/E47.66

P/S7.85

Div. Yield0.00

ROIC (Qtr)0.00

Revenue Growth (1y) (Qtr)18.13

Add ratio to table…

About

Cellebrite DI Ltd. provides AI powered digital investigative and intelligence software solutions that help law enforcement defense intelligence agencies and enterprises manage digital evidence. The company’s tools enable users to collect extract decode and analyze data from mobile phones computers cloud applications and other digital sources. Its solutions support more than 1.5 million legally sanctioned investigations each year assisting in cases ranging from child exploitation and homicide to counter terrorism and financial crime. Defense and intelligence agencies rely on the platform to enhance border security conduct cyber operations and perform malware analysis on mobile devices. Enterprises use the software for internal investigations eDiscovery and to assess the security of mobile applications and other digital assets. By delivering a unified workflow from evidence acquisition to reporting Cellebrite helps customers improve investigative efficiency and reduce case backlog.

Revenue is generated mainly from subscription licenses for the company’s software suite and from professional services such as training certification and advanced lab support. Subscription offerings include perpetual to subscription transitions with most revenue now coming from recurring license fees. In 2025 public sector customers accounted for over 90% of total revenue while the remainder came from corporate and service provider clients. The company reported a dollar based net retention rate of 116% as of December 2025 indicating strong upsell and cross sell activity. Maintenance updates premium features and add on modules also contribute to the overall income stream.

Cellebrite DI Ltd. holds a leading position in the digital forensics market competing with firms such as Magnet Forensics Oxygen Forensics Exterro Nuix and other specialized vendors. Its competitive advantages stem from the broadest device coverage that includes thousands of phone computer and IoT models. The company’s AI powered analytics engine automates data analysis surfaces hidden links and reduces manual review time. Advanced lawful access capabilities enable extraction from the newest smartphones even when locked or encrypted. A unified platform that combines collection analysis sharing and management distinguishes Cellebrite from point solution providers. Continuous investment in research and development ensures the product suite stays ahead of evolving mobile operating systems and emerging threats.

Cellebrite DI Ltd. serves approximately 7,000 customers including about 5,300 government agencies and 1,700 corporations and service providers. No single customer accounted for more than 5% of total revenue in 2025 and the top 25 customers together represented roughly 25% of sales. The client base spans law enforcement agencies at the federal state and local levels defense and intelligence organizations and corporate enterprises across industries such as finance healthcare technology and manufacturing. Geographic diversity is evident with sales distributed across North America Europe Asia Pacific and other regions. Solutions are used in a wide range of investigations including those involving child exploitation human trafficking cybercrime and intellectual property theft.

Investment Thesis

▲ Bull case

Cellebrite's recent FedRAMP High Authorization to Operate (ATO) represents a significant, underappreciated catalyst that could materially accelerate government cloud adoption and expand the company's total addressable market in ways not fully reflected in current guidance. Achieving FedRAMP Level 4 certification is exceptionally rare, with fewer than 100 companies holding this designation, and it is specifically required for U.S. federal agencies seeking cloud-hosted solutions that handle data posing catastrophic risk if compromised. This authorization directly enables Cellebrite to compete for large-scale, mission-critical contracts across defense, intelligence, and law enforcement agencies that were previously inaccessible due to stringent security requirements. Management noted that this opens the door for evaluation and pursuit of Cellebrite's Government Cloud offerings, including the flagship Guardian platform, and highlighted that U.S. federal agencies are actively planning and prioritizing their technology platforms for fiscal 2027. The ATO was sponsored by the U.S. Department of Justice, lending substantial credibility and signaling strong alignment with federal priorities. Given the multi-quarter sales cycles typical in federal procurement, the benefits of this certification are likely to begin accruing in the second half of 2026 and accelerate into 2027, providing a durable tailwind that could drive ARR growth beyond current mid-teens expectations, particularly as agencies increase spending on cyber and digital initiatives tied to fentanyl, opioid crises, and cybersecurity. This structural advantage positions Cellebrite as a sole-source provider in a high-barrier segment, reducing competitive pressure and enhancing pricing power for its cloud-based forensic solutions.
The rapid adoption and overwhelmingly positive feedback from early users of Cellebrite's Genesis AI platform indicate a product-market fit that exceeds internal expectations and could drive faster-than-anticipated revenue conversion, creating a material upside to the company's AI-driven TAM expansion thesis. Despite launching Genesis with zero marketing, pricing, or packaging, the platform attracted over 500 registered users from more than 15 countries within eight weeks—far surpassing the initial expectation of 1–2 dozen adopters. Early adopter testimonials, shared verbatim by management, describe Genesis as a 'quantum leap' in digital evidence analytics, capable of producing life-saving, actionable insights in minutes that would otherwise require weeks of manual review. One user reported identifying 16 additional victims in a child exploitation case within 15 minutes of data ingestion, a task estimated to take two weeks manually. This level of efficacy, particularly in time-sensitive scenarios involving terrorism, child exploitation, and fentanyl trafficking, transforms Genesis from a productivity tool into a mission-critical asset, increasing the likelihood of broad, rapid adoption and budget allocation. Management explicitly stated that their 2026 plan assumed zero AI product-specific revenue, a conservative stance now clearly outdated given the traction observed. The company's assertion that Genesis can be deployed in a day with no training required—turning nontechnical officers into instantaneous productive users—addresses a critical barrier in law enforcement technology adoption and could accelerate penetration across its 7,000-institution installed base. Given the strong word-of-mouth potential highlighted by early users presenting at conferences and the alignment with rising federal appropriations for digital evidence management, Genesis has the potential to become a dominant growth driver sooner than modeled, possibly contributing meaningfully to ARR as early as Q3 2026 and enabling the company to exceed its conservative estimate of capturing just 5% of the $12.5 billion Investigative AI TAM.
Cellebrite's strategic expansion into end-to-end platform offerings—combining advanced unlock capabilities, AI-driven analytics, drone forensics via Corellium, and integrated field-based kiosks—is creating a differentiated value proposition that is increasingly resonating with government customers seeking unified solutions, a trend that could drive higher average revenue per user and reduce churn in ways not yet fully captured by financial metrics. Management emphasized that customers are shifting from purchasing point products to adopting multi-product suites or full platforms, particularly in the defense and intelligence (D&I) space, where bundled solutions addressing the full lifecycle of digital evidence—from extraction at the point of engagement to analysis and case management—are becoming a procurement priority. The integrated field-based kiosk for forensic intelligence and extraction, combined with Corellium's advanced iOS and Android unlock capabilities and Genesis AI analytics, creates a seamless workflow that few competitors can replicate due to Cellebrite's deep expertise in hardware-enabled access and its recent FedRAMP authorization. This end-to-end capability is particularly valuable in high-stakes, time-sensitive operations such as counterterrorism and child exploitation investigations, where speed, accuracy, and chain-of-custody integrity are paramount. The company's success in securing a high-profile federal intelligence agency's urgent need to access a current-generation device—cited by the CEO as a real-world example—underscores the irreplaceable nature of its proprietary unlocking technology in the face of evolving device security. As government budgets increasingly favor platform-based procurements to reduce vendor sprawl and improve interoperability, Cellebrite's expanded portfolio positions it to win larger, more strategic deals, increase attachment rates of complementary products like Guardian Investigate and Drone Forensics, and benefit from longer contract durations and higher renewal rates. This platformization trend, supported by a 35% year-over-year increase in the U.S. federal pipeline and mid-30% growth in EMEA's defense and intelligence sector, suggests a structural shift in customer behavior that could elevate Cellebrite's growth trajectory beyond its current ARR guidance. The appointment of Shiv Ramji as President of Products and Technology—bringing experience from Okta, Amazon, and DigitalOcean in security, AI, and cloud—further strengthens the company's ability to execute on this platform strategy and accelerate innovation in high-growth areas.

Cellebrite's recent FedRAMP High Authorization to Operate (ATO) represents a significant, underappreciated catalyst that could materially accelerate government cloud adoption and expand the company's total addressable market in ways not fully reflected in current guidance. Achieving FedRAMP Level 4 certification is exceptionally rare, with fewer than 100 companies holding this designation, and it is specifically required for U.S. federal agencies seeking cloud-hosted solutions that handle data posing catastrophic risk if compromised. This authorization directly enables Cellebrite to compete for large-scale, mission-critical contracts across defense, intelligence, and law enforcement agencies that were previously inaccessible due to stringent security requirements. Management noted that this opens the door for evaluation and pursuit of Cellebrite's Government Cloud offerings, including the flagship Guardian platform, and highlighted that U.S. federal agencies are actively planning and prioritizing their technology platforms for fiscal 2027. The ATO was sponsored by the U.S. Department of Justice, lending substantial credibility and signaling strong alignment with federal priorities. Given the multi-quarter sales cycles typical in federal procurement, the benefits of this certification are likely to begin accruing in the second half of 2026 and accelerate into 2027, providing a durable tailwind that could drive ARR growth beyond current mid-teens expectations, particularly as agencies increase spending on cyber and digital initiatives tied to fentanyl, opioid crises, and cybersecurity. This structural advantage positions Cellebrite as a sole-source provider in a high-barrier segment, reducing competitive pressure and enhancing pricing power for its cloud-based forensic solutions.
The rapid adoption and overwhelmingly positive feedback from early users of Cellebrite's Genesis AI platform indicate a product-market fit that exceeds internal expectations and could drive faster-than-anticipated revenue conversion, creating a material upside to the company's AI-driven TAM expansion thesis. Despite launching Genesis with zero marketing, pricing, or packaging, the platform attracted over 500 registered users from more than 15 countries within eight weeks—far surpassing the initial expectation of 1–2 dozen adopters. Early adopter testimonials, shared verbatim by management, describe Genesis as a 'quantum leap' in digital evidence analytics, capable of producing life-saving, actionable insights in minutes that would otherwise require weeks of manual review. One user reported identifying 16 additional victims in a child exploitation case within 15 minutes of data ingestion, a task estimated to take two weeks manually. This level of efficacy, particularly in time-sensitive scenarios involving terrorism, child exploitation, and fentanyl trafficking, transforms Genesis from a productivity tool into a mission-critical asset, increasing the likelihood of broad, rapid adoption and budget allocation. Management explicitly stated that their 2026 plan assumed zero AI product-specific revenue, a conservative stance now clearly outdated given the traction observed. The company's assertion that Genesis can be deployed in a day with no training required—turning nontechnical officers into instantaneous productive users—addresses a critical barrier in law enforcement technology adoption and could accelerate penetration across its 7,000-institution installed base. Given the strong word-of-mouth potential highlighted by early users presenting at conferences and the alignment with rising federal appropriations for digital evidence management, Genesis has the potential to become a dominant growth driver sooner than modeled, possibly contributing meaningfully to ARR as early as Q3 2026 and enabling the company to exceed its conservative estimate of capturing just 5% of the $12.5 billion Investigative AI TAM.
Cellebrite's strategic expansion into end-to-end platform offerings—combining advanced unlock capabilities, AI-driven analytics, drone forensics via Corellium, and integrated field-based kiosks—is creating a differentiated value proposition that is increasingly resonating with government customers seeking unified solutions, a trend that could drive higher average revenue per user and reduce churn in ways not yet fully captured by financial metrics. Management emphasized that customers are shifting from purchasing point products to adopting multi-product suites or full platforms, particularly in the defense and intelligence (D&I) space, where bundled solutions addressing the full lifecycle of digital evidence—from extraction at the point of engagement to analysis and case management—are becoming a procurement priority. The integrated field-based kiosk for forensic intelligence and extraction, combined with Corellium's advanced iOS and Android unlock capabilities and Genesis AI analytics, creates a seamless workflow that few competitors can replicate due to Cellebrite's deep expertise in hardware-enabled access and its recent FedRAMP authorization. This end-to-end capability is particularly valuable in high-stakes, time-sensitive operations such as counterterrorism and child exploitation investigations, where speed, accuracy, and chain-of-custody integrity are paramount. The company's success in securing a high-profile federal intelligence agency's urgent need to access a current-generation device—cited by the CEO as a real-world example—underscores the irreplaceable nature of its proprietary unlocking technology in the face of evolving device security. As government budgets increasingly favor platform-based procurements to reduce vendor sprawl and improve interoperability, Cellebrite's expanded portfolio positions it to win larger, more strategic deals, increase attachment rates of complementary products like Guardian Investigate and Drone Forensics, and benefit from longer contract durations and higher renewal rates. This platformization trend, supported by a 35% year-over-year increase in the U.S. federal pipeline and mid-30% growth in EMEA's defense and intelligence sector, suggests a structural shift in customer behavior that could elevate Cellebrite's growth trajectory beyond its current ARR guidance. The appointment of Shiv Ramji as President of Products and Technology—bringing experience from Okta, Amazon, and DigitalOcean in security, AI, and cloud—further strengthens the company's ability to execute on this platform strategy and accelerate innovation in high-growth areas.

▼ Bear case

Cellebrite's aggressive pivot toward AI-driven products like Genesis and Guardian Investigate carries significant execution risks related to pricing strategy, market education, and potential customer hesitation despite strong early feedback, which could delay monetization and undermine the bullish thesis that AI will meaningfully contribute to near-term ARR growth. While early adopter testimonials highlight transformative use cases in child exploitation and counterterrorism, the company has not yet disclosed pricing models for Genesis post-general availability, and management acknowledged that initial pricing decisions are likely to be wrong—either too high to deter adoption or too low to capture value. The reliance on a token-based consumption model introduces uncertainty around customer predictability of costs, particularly for budget-constrained state and local law enforcement agencies that may prefer flat-fee or subscription-based pricing. Furthermore, although Genesis requires no training and can be deployed in a day, agencies must still integrate it into existing workflows, secure approvals for AI use in evidentiary processes, and address concerns around algorithmic bias, auditability, and ethical use—factors that could slow adoption despite enthusiasm for the technology's capabilities. The company's strategy to price aggressively to drive broad adoption risks leaving money on the table if demand proves inelastic, while overestimation of willingness to pay could result in slow uptake. Additionally, the emphasis on AI as a force multiplier for investigator productivity may not translate directly into budget allocation if agencies prioritize hiring or other operational needs over technology investments, especially in jurisdictions facing fiscal constraints. The early user base, while impressive in size and geographic spread, consists largely of self-selected innovators who may not be representative of the broader market, and conversion from free trial to paid subscription remains unproven at scale. Without clear evidence of paid conversions or contractual commitments from these early users, the current enthusiasm may not translate into near-term revenue, creating a risk that AI contributes minimally to 2026 results despite the optimistic TAM estimates of $12.5 billion over four years.
Despite the positive momentum in U.S. federal business and the FedRAMP ATO, Cellebrite remains exposed to the inherent volatility and long sales cycles of government contracting, which could delay the realization of benefits from recent investments and create quarterly revenue volatility that undermines investor confidence in sustained growth. The company acknowledged that U.S. federal business was essentially flat in 2025 due to budget pressures and organizational change, and while the rebound is being driven by stabilized leadership, anticipated cyber-focused appropriations, and elevated geopolitical instability, these factors are inherently unpredictable and subject to sudden shifts. Appropriations bills, even when passed, often experience delays in fund allocation and obligation, meaning that the $30 million in extra dollars cited by management from a few U.S. agencies may not translate into immediate contract awards or revenue recognition. The multi-year nature of large defense and intelligence projects—such as those involving cloud migration or enterprise-wide digital evidence management—means that revenue recognition will be ratable and spread over time, potentially delaying the impact on ARR growth. Furthermore, the reliance on external catalysts like geopolitical tensions or specific legislative appropriations introduces exogenous risk; a de-escalation in international conflict or a shift in federal spending priorities away from cyber and digital initiatives could quickly reverse the current tailwind. The company's dependence on winning large, strategic platform deals also increases exposure to competitive bidding protests, protracted negotiations, and potential loss to incumbents or new entrants, particularly as competitors enhance their own AI and cloud capabilities. While the FedRAMP Level 4 ATO is a strong differentiator, maintaining it requires ongoing compliance, audits, and significant investment, and any lapse could jeopardize eligibility for federal cloud contracts. The integration of acquired assets like Corellium and SCG continues to pose operational challenges, and any delays in harmonizing these technologies into a cohesive platform could slow time-to-market for combined offerings, reducing the expected synergies from these acquisitions.
Cellebrite's growth in EMEA and Asia Pacific, while encouraging, may be overstated as a sustainable driver of long-term ARR expansion due to regional dependencies on defense and intelligence spending that correlates with volatile geopolitical conditions and limited diversification into commercial or civilian markets outside of law enforcement and government sectors. The company highlighted that EMEA's ARR growth increased 10 percentage points year-over-year to 25%, driven primarily by the defense and intelligence sector growing in the mid-30% range—a direct result of a strategic focus launched one year ago. Similarly, Asia Pacific growth of 21% was influenced by regional dynamics, though specific drivers were less detailed. This concentration in government-facing segments, particularly defense and intelligence, makes revenue in these regions highly sensitive to changes in national security budgets, defense procurement cycles, and international relations. Unlike the U.S. federal market, which benefits from large, multi-year appropriations and a stable base of agencies, many EMEA and Asia Pacific countries have smaller, more fragmented law enforcement and defense entities with less predictable budgeting cycles and greater susceptibility to austerity measures or political shifts. Furthermore, Cellebrite has limited penetration into non-government commercial markets such as corporate investigations, cybersecurity firms, or private security providers, which could offer more stable, recurring revenue streams less tied to federal budget cycles. The company's reliance on word-of-mouth and conference-based adoption (evidenced by the C2C event attracting 850 attendees) may not scale effectively in regions with diverse languages, regulatory environments, and procurement practices. Without a clear path to diversify beyond government clients or to develop horizontal use cases for its AI and unlocking technologies in commercial sectors, Cellebrite's growth remains tethered to the timing and volume of government spending, which—while currently favorable—could fluctuate significantly from year to year, creating uncertainty around the durability of its current growth trajectory beyond the near term.

Cellebrite's aggressive pivot toward AI-driven products like Genesis and Guardian Investigate carries significant execution risks related to pricing strategy, market education, and potential customer hesitation despite strong early feedback, which could delay monetization and undermine the bullish thesis that AI will meaningfully contribute to near-term ARR growth. While early adopter testimonials highlight transformative use cases in child exploitation and counterterrorism, the company has not yet disclosed pricing models for Genesis post-general availability, and management acknowledged that initial pricing decisions are likely to be wrong—either too high to deter adoption or too low to capture value. The reliance on a token-based consumption model introduces uncertainty around customer predictability of costs, particularly for budget-constrained state and local law enforcement agencies that may prefer flat-fee or subscription-based pricing. Furthermore, although Genesis requires no training and can be deployed in a day, agencies must still integrate it into existing workflows, secure approvals for AI use in evidentiary processes, and address concerns around algorithmic bias, auditability, and ethical use—factors that could slow adoption despite enthusiasm for the technology's capabilities. The company's strategy to price aggressively to drive broad adoption risks leaving money on the table if demand proves inelastic, while overestimation of willingness to pay could result in slow uptake. Additionally, the emphasis on AI as a force multiplier for investigator productivity may not translate directly into budget allocation if agencies prioritize hiring or other operational needs over technology investments, especially in jurisdictions facing fiscal constraints. The early user base, while impressive in size and geographic spread, consists largely of self-selected innovators who may not be representative of the broader market, and conversion from free trial to paid subscription remains unproven at scale. Without clear evidence of paid conversions or contractual commitments from these early users, the current enthusiasm may not translate into near-term revenue, creating a risk that AI contributes minimally to 2026 results despite the optimistic TAM estimates of $12.5 billion over four years.
Despite the positive momentum in U.S. federal business and the FedRAMP ATO, Cellebrite remains exposed to the inherent volatility and long sales cycles of government contracting, which could delay the realization of benefits from recent investments and create quarterly revenue volatility that undermines investor confidence in sustained growth. The company acknowledged that U.S. federal business was essentially flat in 2025 due to budget pressures and organizational change, and while the rebound is being driven by stabilized leadership, anticipated cyber-focused appropriations, and elevated geopolitical instability, these factors are inherently unpredictable and subject to sudden shifts. Appropriations bills, even when passed, often experience delays in fund allocation and obligation, meaning that the $30 million in extra dollars cited by management from a few U.S. agencies may not translate into immediate contract awards or revenue recognition. The multi-year nature of large defense and intelligence projects—such as those involving cloud migration or enterprise-wide digital evidence management—means that revenue recognition will be ratable and spread over time, potentially delaying the impact on ARR growth. Furthermore, the reliance on external catalysts like geopolitical tensions or specific legislative appropriations introduces exogenous risk; a de-escalation in international conflict or a shift in federal spending priorities away from cyber and digital initiatives could quickly reverse the current tailwind. The company's dependence on winning large, strategic platform deals also increases exposure to competitive bidding protests, protracted negotiations, and potential loss to incumbents or new entrants, particularly as competitors enhance their own AI and cloud capabilities. While the FedRAMP Level 4 ATO is a strong differentiator, maintaining it requires ongoing compliance, audits, and significant investment, and any lapse could jeopardize eligibility for federal cloud contracts. The integration of acquired assets like Corellium and SCG continues to pose operational challenges, and any delays in harmonizing these technologies into a cohesive platform could slow time-to-market for combined offerings, reducing the expected synergies from these acquisitions.
Cellebrite's growth in EMEA and Asia Pacific, while encouraging, may be overstated as a sustainable driver of long-term ARR expansion due to regional dependencies on defense and intelligence spending that correlates with volatile geopolitical conditions and limited diversification into commercial or civilian markets outside of law enforcement and government sectors. The company highlighted that EMEA's ARR growth increased 10 percentage points year-over-year to 25%, driven primarily by the defense and intelligence sector growing in the mid-30% range—a direct result of a strategic focus launched one year ago. Similarly, Asia Pacific growth of 21% was influenced by regional dynamics, though specific drivers were less detailed. This concentration in government-facing segments, particularly defense and intelligence, makes revenue in these regions highly sensitive to changes in national security budgets, defense procurement cycles, and international relations. Unlike the U.S. federal market, which benefits from large, multi-year appropriations and a stable base of agencies, many EMEA and Asia Pacific countries have smaller, more fragmented law enforcement and defense entities with less predictable budgeting cycles and greater susceptibility to austerity measures or political shifts. Furthermore, Cellebrite has limited penetration into non-government commercial markets such as corporate investigations, cybersecurity firms, or private security providers, which could offer more stable, recurring revenue streams less tied to federal budget cycles. The company's reliance on word-of-mouth and conference-based adoption (evidenced by the C2C event attracting 850 attendees) may not scale effectively in regions with diverse languages, regulatory environments, and procurement practices. Without a clear path to diversify beyond government clients or to develop horizontal use cases for its AI and unlocking technologies in commercial sectors, Cellebrite's growth remains tethered to the timing and volume of government spending, which—while currently favorable—could fluctuate significantly from year to year, creating uncertainty around the durability of its current growth trajectory beyond the near term.

Geographical Breakdown of Revenue (2025)

Peer Comparison

Companies in the Software - Infrastructure

S.No.	Ticker	Company	Market Cap	P/E	P/S	Total Debt (Qtr)
1	MSFT	Microsoft Corp	2,853.66 Bn	22.79	8.97	40.26 Bn
2	ORCL	Oracle Corp	408.21 Bn	23.92	6.06	122.34 Bn
3	PLTR	Palantir Technologies Inc.	300.98 Bn	131.24	57.61	-
4	PANW	Palo Alto Networks Inc	247.84 Bn	193.34	25.05	-
5	CRWD	CrowdStrike Holdings, Inc.	193.63 Bn	-1,201.41	40.24	0.75 Bn
6	FTNT	Fortinet, Inc.	117.45 Bn	60.08	16.52	0.50 Bn
7	NET	Cloudflare, Inc.	86.88 Bn	-1,001.47	37.31	1.29 Bn
8	SNPS	Synopsys Inc	86.18 Bn	1,416.99	10.76	10.04 Bn

Research Tools

Developers

About

Investment Thesis

Product and Service Breakdown of Revenue (2025)

Geographical Breakdown of Revenue (2025)

Peer Comparison

Research Tools

Developers

About

Investment Thesis

Product and Service Breakdown of Revenue (2025)

Geographical Breakdown of Revenue (2025)

Peer Comparison

Create an account

Sign In

Reset Password